Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant.

Slides:

Advertisements

Similar presentations

Blood lactate level during extracorporeal life support as a surrogate marker for survival Sung Jun Park, MD, Sang-pil Kim, MD, PhD, Joon Bum Kim, MD,

Advertisements

Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma

Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant.

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, MD, MSc, Ronald Feld, MD,

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma

Pleomorphic carcinoma of the lung: A surgical outcome

Blood lactate level during extracorporeal life support as a surrogate marker for survival Sung Jun Park, MD, Sang-pil Kim, MD, PhD, Joon Bum Kim, MD,

Personalized cardiac surgery: Can noninvasive flow imaging lead to individualized resection strategies for bicuspid aortopathy? Nicholas D. Andersen,

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Role of Integrated 18-Fluorodeoxyglucose Position Emission Tomography-Computed Tomography in Patients Surveillance after Multimodality Therapy of Malignant.

Sleeve lung resection for lung cancer: Analysis according to the type of procedure Kazumichi Yamamoto, MD, Yoshihiro Miyamoto, MD, Akihiro Ohsumi, MD,

William M. DeCampli, MD, PhD

How should we treat air leaks?

Go on-pump or off-pump in diabetic patients?

What is the best approach for surgery of malignant pleural mesothelioma? It is to put our efforts into obtaining trustworthy evidence for practice Tom.

Bigger The Journal of Thoracic and Cardiovascular Surgery

Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,

The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma Yasuhiro Tsutani, MD, PhD, Yoshihiro.

The lord of the rings Antonio Miceli, MD, PhD

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Thymic carcinoma outcomes and prognosis: Results of an international analysis Usman Ahmad, MD, Xiaopan Yao, PhD, Frank Detterbeck, MD, James Huang, MD,

Outcome after surgery for prosthetic valve endocarditis and the impact of preoperative treatment Herko Grubitzsch, MD, PhD, Andreas Schaefer, Christoph.

Yang Zhang, MD, Haiquan Chen, MD, PhD

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Support Your Specialty

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

A first start for lung transplantation?

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients Raja.

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: Result in a cohort of 203 resection specimens Aneil.

The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the.

Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon

Attachment disorder in thoracoabdominal surgery

Pleurectomy/Decortication is Superior to Extrapleural Pneumonectomy in the Multimodality Management of Patients with Malignant Pleural Mesothelioma Loïc.

Phase 2 Study of Sorafenib in Malignant Mesothelioma Previously Treated with Platinum-Containing Chemotherapy Sophie Papa, MRCP, PhD, Sanjay Popat, FRCP,

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes Sitaram M. Emani, MD The Journal of Thoracic.

T. Brett Reece, MD The Journal of Thoracic and Cardiovascular Surgery

Sebastien Gilbert, MD, Andre B. Martel, BSc, Andrew J

Positron emission tomography predicts survival in malignant pleural mesothelioma Raja M. Flores, MD, Timothy Akhurst, MD, Mithat Gonen, PhD, Maureen Zakowski,

Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural.

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

The continuing challenge of congenital heart disease in China

Bicuspid aortopathy: Seeing the forest for the trees

Raja M. Flores, MD The Journal of Thoracic and Cardiovascular Surgery

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

Therapeutic R2 resection for pleural mesothelioma

“The more things change…”: The challenges ahead

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Preoperative PFTs: The answer is blowing in the wind

The evolution of cardiothoracic critical care

European Society of Thoracic Surgeons preoperative mediastinal staging guidelines: From face validity to external validity Alessandro Brunelli, MD The.

Who should decide margin length in pulmonary excision of lung cancer?

Did you like Terminator 3 better than Terminator 2

How do we follow up our patients

Journal changes and initiatives

Calpain inhibitors: The aspirin of the 21st century?

Deciding how much to pay for effective care

Presentation transcript:

Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: A 10-year experience Loïc Lang-Lazdunski, MD, PhD, Andrea Bille, MD, Sophie Papa, MD, Stuart Marshall, FRCA, Rohit Lal, PhD, Carlotta Galeone, ScD, PhD, David Landau, FRCR, Jeremy Steele, MD, FRCP, James Spicer, PhD, FRCP The Journal of Thoracic and Cardiovascular Surgery Volume 149, Issue 2, Pages 558-566 (February 2015) DOI: 10.1016/j.jtcvs.2014.10.041 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Flow chart of patients (2004-2013): 14 had preoperative chemotherapy and 83 adjuvant chemotherapy. All received adjuvant prophylactic radiotherapy. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 558-566DOI: (10.1016/j.jtcvs.2014.10.041) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Global overall survival, n = 102 (Kaplan–Meier). The Journal of Thoracic and Cardiovascular Surgery 2015 149, 558-566DOI: (10.1016/j.jtcvs.2014.10.041) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Comparative survival according to histology (Kaplan–Meier). CI, Confidence interval. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 558-566DOI: (10.1016/j.jtcvs.2014.10.041) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Comparative survival according to nodal status (N0 vs N1/N2) (Kaplan–Meier). CI, Confidence interval. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 558-566DOI: (10.1016/j.jtcvs.2014.10.041) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Comparative survival according to completeness of resection (R0-R1 vs R2) (Kaplan–Meier). CI, Confidence interval. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 558-566DOI: (10.1016/j.jtcvs.2014.10.041) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions